Geron (GERN)
(Delayed Data from NSDQ)
$4.69 USD
+0.03 (0.64%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $4.70 +0.01 (0.21%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
Geron Corporation [GERN]
Reports for Purchase
Showing records 161 - 180 ( 243 total )
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
We are placing Geron Corp. under review due to the departure of the covering analyst
Provider: RODMAN & RENSHAW, CO.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
1Q12 UPDATE - BUILDING AN ONCOLOGY FRANCHISE - KEY DRIVERS EXPECTED IN 4Q12
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
1Q12 UPDATE - BUILDING AN ONCOLOGY FRANCHISE - KEY DRIVERS EXPECTED IN 4Q12
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Highlights From Meeting with Management - Several Key Data Drivers Expected in 2012
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Highlights From Meeting with Management - Several Key Data Drivers Expected in 2012
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Biotechnology -SUMMARIES FROM PRESENTATIONS OF COMPANIES UNDER COVERAGE OR REVIEW
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Biotechnology -SUMMARIES FROM PRESENTATIONS OF COMPANIES UNDER COVERAGE OR REVIEW
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R